醫療影像及報告實作指引
0.1.0 - DSTU0 ci-build

醫療影像及報告實作指引 - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: NASH-Necroinflammatory Grading - TTL Representation

Draft as of 2024-07-29

Raw ttl | Download


@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

 a fhir:CodeSystem ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "NASH-Necroinflammatory-Grading"] ; # 
  fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem NASH-Necroinflammatory-Grading</b></p><a name=\"NASH-Necroinflammatory-Grading\"> </a><a name=\"hcNASH-Necroinflammatory-Grading\"> </a><a name=\"hcNASH-Necroinflammatory-Grading-en-US\"> </a><p>This case-sensitive code system <code>https://hapi.fhir.tw/fhir/CodeSystem/NASH-Necroinflammatory-Grading</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">1<a name=\"NASH-Necroinflammatory-Grading-1\"> </a></td><td>Grade 1 (mild)</td><td>Steatosis (mainly macrovesicular) involving up to 66% of lobules; occasional balloned perivenular hepatocytes; scattered neutrophils with or without lymphocytes; no or mild chronic portal inflammation.</td></tr><tr><td style=\"white-space:nowrap\">2<a name=\"NASH-Necroinflammatory-Grading-2\"> </a></td><td>Grade 2 (moderate)</td><td>Steatosis of any degree; obvious ballooning (mainly perivenular); intralobular neutrophils, may be associated with perivenular pericellular fibrosis if evident; mild to moderate portal and intralobular chronic inflammation.</td></tr><tr><td style=\"white-space:nowrap\">3<a name=\"NASH-Necroinflammatory-Grading-3\"> </a></td><td>Grade 3 (severe)</td><td>Panlobular steatosis; obvious perivenular ballooning and disarray; marked lobular inflammation; neutrophils may be concentrated in perivenular areas of ballooning and in areas of pericellular fibrosis if evident. Portal inflammation mild or moderate.</td></tr></table></div>"
  ] ; # 
  fhir:url [ fhir:v "https://hapi.fhir.tw/fhir/CodeSystem/NASH-Necroinflammatory-Grading"^^xsd:anyURI] ; # 
  fhir:version [ fhir:v "0.1.0"] ; # 
  fhir:name [ fhir:v "NecroinflammatoryGrading"] ; # 
  fhir:title [ fhir:v "NASH-Necroinflammatory Grading"] ; # 
  fhir:status [ fhir:v "draft"] ; # 
  fhir:experimental [ fhir:v "false"^^xsd:boolean] ; # 
  fhir:date [ fhir:v "2024-07-29T16:27:07+08:00"^^xsd:dateTime] ; # 
  fhir:publisher [ fhir:v "CYLAB"] ; # 
  fhir:description [ fhir:v "NASH-NecroinflammatoryGrading"] ; # 
  fhir:caseSensitive [ fhir:v "true"^^xsd:boolean] ; # 
  fhir:content [ fhir:v "complete"] ; # 
  fhir:count [ fhir:v "3"^^xsd:nonNegativeInteger] ; # 
  fhir:concept ( [
fhir:code [ fhir:v "1" ] ;
fhir:display [ fhir:v "Grade 1 (mild)" ] ;
fhir:definition [ fhir:v "Steatosis (mainly macrovesicular) involving up to 66% of lobules; occasional balloned perivenular hepatocytes; scattered neutrophils with or without lymphocytes; no or mild chronic portal inflammation." ]
  ] [
fhir:code [ fhir:v "2" ] ;
fhir:display [ fhir:v "Grade 2 (moderate)" ] ;
fhir:definition [ fhir:v "Steatosis of any degree; obvious ballooning (mainly perivenular); intralobular neutrophils, may be associated with perivenular pericellular fibrosis if evident; mild to moderate portal and intralobular chronic inflammation." ]
  ] [
fhir:code [ fhir:v "3" ] ;
fhir:display [ fhir:v "Grade 3 (severe)" ] ;
fhir:definition [ fhir:v "Panlobular steatosis; obvious perivenular ballooning and disarray; marked lobular inflammation; neutrophils may be concentrated in perivenular areas of ballooning and in areas of pericellular fibrosis if evident. Portal inflammation mild or moderate." ]
  ] ) . #